Cargando…
Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography
BACKGROUND: Several studies have revealed that glucose fluctuations provoke oxidative stress that leads to endothelial cell dysfunction, progression of coronary atherosclerosis, and plaque vulnerability. However, little is known regarding their effect on neointimal growth after stenting in patients...
Autores principales: | Kuroda, Masaru, Shinke, Toshiro, Otake, Hiromasa, Sugiyama, Daisuke, Takaya, Tomofumi, Takahashi, Hachidai, Terashita, Daisuke, Uzu, Kenzo, Tahara, Natsuko, Kashiwagi, Daiji, Kuroda, Koji, Shinkura, Yuto, Nagasawa, Yoshinori, Sakaguchi, Kazuhiko, Hirota, Yushi, Ogawa, Wataru, Hirata, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875633/ https://www.ncbi.nlm.nih.gov/pubmed/27208906 http://dx.doi.org/10.1186/s12933-016-0395-4 |
Ejemplares similares
-
Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2015) -
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease
por: Yamamoto, Hiroyuki, et al.
Publicado: (2018) -
The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial
por: Yamamoto, Hiroyuki, et al.
Publicado: (2021) -
Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy
por: Yamamoto, Hiroyuki, et al.
Publicado: (2020) -
Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study
por: Yoshida, Naofumi, et al.
Publicado: (2017)